Ferlito S, Del Campo F, Di Vincenzo S, Damante G, Coco R, Branca S, Fichera C
Farmaco Sci. 1983 Apr;38(4):248-54.
Since the C-peptide Radioimmuno active/Immuno Reactive Insulin (CPR/IRI) molar ratio is considered as an index of insulin hepatic extraction and tissue receptor binding, the AA. investigated the effects of metformin on this index after glucagon infusion in non-insulin dependent diabetics. Fourteen lean subjects (aged 48 to 67 years, mean 54 +/- 7) with non-insulin dependent diabetes were studied. At 9.00 a.m. each subject after overnight fasting, underwent glucagon infusion (1 mg i.v. diluted in 250 ml of saline, infused at a rate of 8.3 gamma/min for 2 hours); blood specimen were obtained at --15, 0, 30, 60, 90, 120 min. This test was repeated after a five-day treatment with metformin (1.5 g per os). For each sample plasma glucose by glucose oxidase method, plasma insulin and C-peptide by Radio Immuno Assay (RIA) method were determined. After treatment with metformin the hyperglycemia induced by glucagon was not influenced; nevertheless insulin and C-peptide plasma levels showed an evident reduction while CPR/IRI molar ratio was unchanged. The AA. suppose an indirect effect of metformin upon beta cells, namely a less pancreatic insulin requirement, mediated by an improvement of glucose utilization.
由于C肽放射免疫活性/免疫反应性胰岛素(CPR/IRI)摩尔比被视为胰岛素肝脏摄取和组织受体结合的指标,研究人员调查了二甲双胍对非胰岛素依赖型糖尿病患者在输注胰高血糖素后该指标的影响。研究了14名非胰岛素依赖型糖尿病的瘦受试者(年龄48至67岁,平均54±7岁)。在上午9点,每位受试者隔夜禁食后,接受胰高血糖素输注(1毫克静脉注射,稀释于250毫升生理盐水中,以8.3微克/分钟的速度输注2小时);在-15、0、30、60、90、120分钟采集血样。在用二甲双胍(1.5克口服)进行为期五天的治疗后重复该试验。对于每个样本,通过葡萄糖氧化酶法测定血浆葡萄糖,通过放射免疫测定(RIA)法测定血浆胰岛素和C肽。用二甲双胍治疗后,胰高血糖素诱导的高血糖未受影响;然而,胰岛素和C肽血浆水平明显降低,而CPR/IRI摩尔比未改变。研究人员推测二甲双胍对β细胞有间接作用,即通过改善葡萄糖利用介导的胰腺胰岛素需求减少。